Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Broncho-Vaxom in LPS challenge model in healthy volunteers
2012-000712-29Phase 2Completed
- Sponsor
- OM Pharma
- Start
- Jun 2012
- Modality
- Whole Cell Cancer Vaccines → Cancer Vaccines → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2 trial of OM-85 in recurrent respiratory tract infection (RRTI), sponsored by OM Pharma. Primary endpoint: Change in salivary secretory IgA. Started Jun 2012; status: completed.
02
Drugs
OM-85
03
Conditions
recurrent respiratory tract infection (RRTI)
Beyond the preview
Go deeper on 2012-000712-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000712-29.